Prolynx Names Simon Harnest as Chief Financial Officer and Amer Mirza, PhD, as Chief Scientific Officer as It Advances Multi-Program Obesity and Metabolic Disease Portfolio

Summary

Prolynx announced the appointments of Simon Harnest as Chief Financial Officer and Amer Mirza, PhD, as Chief Scientific Officer to support its obesity and metabolic disease portfolio advancement.